Impact of diabetes on the progression of Alzheimer’s disease via trajectories of amyloid–tau–neurodegeneration (ATN) biomarkers
Our study suggests that DM may increase the risk of AD by accelerating each step of the A-T-N cascade in the prodromal stage of AD, underscoring the importance of DM management in preventing the MCI conversion to AD.
Authors
- Eosu Kim (ORCID: https://orcid.org/0000-0001-9472-9465)
- Eun Woo Kim (ORCID: https://orcid.org/0009-0009-2966-0292)
- Keun You Kim (ORCID: https://orcid.org/0000-0001-7192-2828)
Institutions
- Yonsei University (KR)
- Seoul Metropolitan Government (KR)
- New Generation University College (ET)
- Seoyeong University (KR)
Publication Details
- Journal
- The journal of nutrition health & aging
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1016/j.jnha.2024.100444
- Citations
- 5
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- U.S. Department of Defense
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Biogen
- University of Southern California
- Meso Scale Diagnostics
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- Northern California Institute for Research and Education
- National Research Foundation
- National Research Foundation of Korea
- Eisai
- Servier
- H. Lundbeck A/S
- Ministry of Science and ICT, South Korea
- IXICO
- National Institutes of Health
- Genentech
- Canadian Institutes of Health Research